Literature DB >> 25451033

Traceless splicing enabled by substrate-induced activation of the Nostoc punctiforme Npu DnaE intein after mutation of a catalytic cysteine to serine.

Manoj Cheriyan1, Siu-Hong Chan1, Francine Perler2.   

Abstract

Inteins self-catalytically cleave out of precursor proteins while ligating the surrounding extein fragments with a native peptide bond. Much attention has been lavished on these molecular marvels with the hope of understanding and harnessing their chemistry for novel biochemical transformations including coupling peptides from synthetic or biological origins and controlling protein function. Despite an abundance of powerful applications, the use of inteins is still hampered by limitations in our understanding of their specificity (defined as flanking sequences that permit splicing) and the challenge of inserting inteins into target proteins. We examined the frequently used Nostoc punctiforme Npu DnaE intein after the C-extein cysteine nucleophile (Cys+1) was mutated to serine or threonine. Previous studies demonstrated reduced rates and/or splicing yields with the Npu DnaE intein after mutation of Cys+1 to Ser+1. In this study, genetic selection identified extein sequences with Ser+1 that enabled the Npu DnaE intein to splice with only a 5-fold reduction in rate compared to the wild-type Cys+1 intein and without mutation of the intein itself to activate Ser+1 as a nucleophile. Three different proteins spliced efficiently after insertion of the intein flanked by the selected sequences. We then used this selected specificity to achieve traceless splicing in a targeted enzyme at a location predicted by primary sequence similarity to only the selected C-extein sequence. This study highlights the latent catalytic potential of the Npu DnaE intein to splice with an alternative nucleophile and enables broader intein utility by increasing insertion site choices.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  enzyme mechanism; extein specificity; genetic selection; intein; protein engineering

Mesh:

Substances:

Year:  2014        PMID: 25451033     DOI: 10.1016/j.jmb.2014.10.025

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina.

Authors:  Patrizia Tornabene; Ivana Trapani; Renato Minopoli; Miriam Centrulo; Mariangela Lupo; Sonia de Simone; Paola Tiberi; Fabio Dell'Aquila; Elena Marrocco; Carolina Iodice; Antonella Iuliano; Carlo Gesualdo; Settimio Rossi; Laura Giaquinto; Silvia Albert; Carel B Hoyng; Elena Polishchuk; Frans P M Cremers; Enrico M Surace; Francesca Simonelli; Maria A De Matteis; Roman Polishchuk; Alberto Auricchio
Journal:  Sci Transl Med       Date:  2019-05-15       Impact factor: 19.319

2.  Sequential formation of two branched intermediates during protein splicing of class three inteins.

Authors:  Kazuo Tori; Francine Perler
Journal:  Extremophiles       Date:  2016-10-04       Impact factor: 2.395

3.  A functional interplay between intein and extein sequences in protein splicing compensates for the essential block B histidine.

Authors:  Kristina Friedel; Monika A Popp; Julian C J Matern; Emerich M Gazdag; Ilka V Thiel; Gerrit Volkmann; Wulf Blankenfeldt; Henning D Mootz
Journal:  Chem Sci       Date:  2018-10-03       Impact factor: 9.825

4.  Off-Pathway-Sensitive Protein-Splicing Screening Based on a Toxin/Antitoxin System.

Authors:  Hannes M Beyer; Hideo Iwaï
Journal:  Chembiochem       Date:  2019-07-03       Impact factor: 3.164

5.  SufB intein splicing in Mycobacterium tuberculosis is influenced by two remote conserved N-extein histidines.

Authors:  Sunita Panda; Ananya Nanda; Nilanjan Sahu; Deepak K Ojha; Biswaranjan Pradhan; Anjali Rai; Amol R Suryawanshi; Nilesh Banavali; Sasmita Nayak
Journal:  Biosci Rep       Date:  2022-03-31       Impact factor: 3.840

6.  Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A.

Authors:  Federica Esposito; Hristiana Lyubenova; Patrizia Tornabene; Stefano Auricchio; Antonella Iuliano; Edoardo Nusco; Simone Merlin; Cristina Olgasi; Giorgia Manni; Marco Gargaro; Francesca Fallarino; Antonia Follenzi; Alberto Auricchio
Journal:  EMBO Mol Med       Date:  2022-05-02       Impact factor: 14.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.